Previous studies have confirmed that ectopic expression of LIMK1 was associated with the progression of several tumor types, such as colorectal cancer, gastric cancer, prostate cancer, and breast cancer (Davila et al., 2003; McConnell et al., 2011; You et al., 2015; Liao et al., 2017). This evidence concerns the gene LIMK1 and neoplasm.